CD14 and Huntington disease: Based on the CD14 and CD16 expression, we observed a significant decrease in the percentage of classical CD14+CD16− monocytes in HD patients compared to healthy subjects (controls) (p < 0.05), while the percentages of intermediate CD14+CD16+ and non-classical CD14−CD16+ monocytes was similar in the two groups (Figure 1A).